ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma. Liu Z, Zhang L, Jin K, Zeng H, et al. Clin Cancer Res 2025;31:4311-4322.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Z, Zhang L, Jin K, Zeng H, et al. ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma. Clin Cancer Res 2025;31:4311-4322.
PMID: 40788182